| Literature DB >> 18672956 |
Vincent J Willey1, Frank Kopenski, Grant D Lawless.
Abstract
Chronic and severe health problems place an enormous financial burden on individuals, employers, and health plan providers, requiring all to make tough decisions about healthcare. Specialty pharmaceuticals are increasingly attractive treatment options, but employers need tangible ways to incorporate these medications into benefit plans. Benefit managers can take a proactive role in addressing cost and compliance issues, using evidence-based data about true patient costs to develop policies that encourage employees to seek appropriate care. Achieving savings in direct and indirect costs will require more than shifting coverage, which can lead to nonadherence and increase costs elsewhere.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18672956
Source DB: PubMed Journal: Am J Manag Care ISSN: 1088-0224 Impact factor: 2.229